With a brand new acquisition, Fleury lands within the Minas Gerais market

Fleury has already disbursed more than BRL 1 billion in acquisitions since April 2021

At the end of June of this year, Fleury announced to the market an agreement for the merger with the mining group Hermes Pardini, in a transaction valued at R$ 2.5 billion and which still depends on the approval of the Administrative Council for Economic Defense (Cade). .

Waiting for a response from the agency, the diagnostic medicine group has just completed another move in its M&A wake, involving a fellow countryman of Pardini and marking its entry into the Minas Gerais market.

Fleury announced earlier this Monday, October 3rd, the acquisition of 100% of the operation of Méthodos, a company that provides diagnostic services and clinical analysis through 26 units distributed in 15 cities in the southern region of Minas Gerais. .

The check, however, is much more modest compared to the amounts involved in the merger with Pardini. The group will pay R$ 27.37 million before deductions and adjustments. This is the ninth acquisition made by Fleury since Jeane Tsutsui took over the operation in April 2021.

In these agreements, the group has already invested more than R$ 1 billion. Exactly one week ago, the company announced the acquisition of the Retina Clinic units in São Paulo, for R$ 21 million. Four months earlier, he bought Saha for R$120 million.

Founded in 1986, Méthodos reported gross revenue of R$51.7 million last year. In a relevant fact, Fleury highlighted that the acquisition is in line with the strategy of expanding its healthcare ecosystem and with its regional expansion.

After this first footing in Minas Gerais, the perspective is that the Fleury operation will gain a much larger scale from the association with Pardini, which, among other assets, has a base of 172 own units, mostly in the market miner. Fleury, in turn, has 315 units in the country.

At the time they announced the agreement, Fleury and Pardini estimated that the business combination would result in an annual increase in Ebitda between R$160 million and R$190 million. The new operation would result in a company with annual revenue of R$ 6.1 billion.

Fleury’s shares closed this Monday’s trading session at R$18.56, up 4.98%. In the year, the papers accumulated an appreciation of 3.16%. The group is valued at R$ 5.89 billion.

Source: Neofeed